Compliance with RSV prophylaxis: Global physicians’ perspectives

Respiratory syncytial virus (RSV) is a significant cause of morbidity in high-risk infants. Palivizumab is proven to prevent serious RSV disease, but compliance with prophylaxis (monthly doses during the RSV season) is essential to ensure protection. We invited 453 pediatricians to participate in a...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Anderson, Kari S, Mullally, Victoria M, Fredrick, Linda M, Campbell, Andrew L
Format: Artigo
Langue:Inglês
Publié: Dove Medical Press 2009
Sujets:
Short Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2778415/
https://ncbi.nlm.nih.gov/pubmed/19936162
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires